About iTMT


Officially launched in 2017, the TransMedTech Institute (iTMT) is a transdisciplinary, open collaboration initiative that focuses on the development of innovative medical technologies to meet the needs of the healthcare community and to train the next generation of the medical technology sector.

The TransMedTech Institute is an initiative led by Polytechnique Montréal with the collaboration of four other founding institutions (CHU Sainte-Justine, Université de Montréal, CHUM, Jewish General Hospital of Montreal) and some thirty other partners.

Polytechnique MontrealUniversité de MontrealCHU Sainte-Justine Le centre hospitalier universitaire mère-enfant, Université de MontréalHôpital général JuifCHUM Centre Hospitalier de l'Université de Montreal


The iTMT Living Lab is a transdisciplinary open innovation platform where engineers, scientists, students, clinicians, patients, caregivers and other health technology users, the medical technology industry, health system stakeholders and policy makers are at the center of an integrative and collaborative process.

This environment provides a framework for the development, validation and implementation of innovative medical technologies that address unmet needs.

With $95 million in support from the Canada First Research Excellence Fund, the Fonds de recherche du Québec, the Ministère de l’Économie et de l’Innovation du Québec and several other partners, the TransMedTech Institute is led by Carl-Éric Aubin, a full professor of mechanical engineering at Polytechnique Montréal and a researcher at CHU Sainte-Justine, who has won numerous awards for his decisive and innovative contributions to the treatment of musculoskeletal diseases.

“The TransMedTech Institute is a unique initiative that, through its positioning as a sectoral hub of excellence in biomedical engineering and medical technologies, is leading to innovations that have the potential to transform the lives of patients and have a significant impact on the healthcare system and the medical industry.”

Carl-Éric Aubin, Executive and Scientific Director of the TransMedTech Institute

Read more in our 2017-2021 mid-term report



The TransMedTech Institute aims to support innovation in medical technologies that meet the needs of users and the healthcare community, in order to facilitate and catalyze their development and implementation in the healthcare system.

We also aim to train the next generation of medical technology leaders and to support the industry and the innovation community.


To have a significant impact on healthcare, the medical technology industry, the training of highly qualified professionals and society.


The values that drive us:

Excellence, relevance, rigour, collaboration, innovation, agility

Sectors and Technological Axes

Prioritized medical areas and technological axes

In accompanying and supporting its research projects, the TransMedTech Institute prioritizes the following medical sectors and technological axes:

Medical areas

Maladies neuro-musculosquelettiques

Neuro-musculoskeletal diseases

Maladies cardiovasculaires

Cardiovascular diseases



Technological axes

Diagnostic, prognostic and theranostic technologies

  • Multimodal and interventional imaging
  • Laser therapies, biophotonic probes
  • Microfluidics, precision medicine
  • Sensors, biomarker measurement

Therapeutic technologies

  • Biomaterials, implants, surgical devices
  • Nanotechnologies
  • Simulation, navigation and surgical robotics
  • Minimally-invasive intervention treatments

Rehabilitation technologies

  • Orthoses, prostheses
  • Technical aids
  • Mobility, posture, restoration of functions

Transversal technological axis

Modeling & Simulation

Data Science

Artificial Intelligence

Axis – Covid-19 challenge

Solutions for urgent health system needs